Sign in
A randomized phase II trial of concurrent chemoradiation of oral vinorelbine and two doses of radiotherapy, 60 and 66 Gy, in local-regionally advanced non-small cell lung cancer (LA-NSCLC)
Journal article   Peer reviewed

A randomized phase II trial of concurrent chemoradiation of oral vinorelbine and two doses of radiotherapy, 60 and 66 Gy, in local-regionally advanced non-small cell lung cancer (LA-NSCLC)

Olfred Hansen, Marianne Knap, Azza Khalil, Christa Haugaard Nyhus, Tine McCulloch, Bente Holm, Carsten Brink, Lone Hoffmann and Tine Schytte
Journal of clinical oncology, Vol.32(15_suppl), pp.7557-7557
20/05/2014

Abstract

Abstract only

Metrics

1 Record Views

Details